Erlotinib(埃罗替尼) is a quinazoline derivative and antineoplastic agent that functions as a protein kinase inhibitor for EGFR associated tyrosine kinase.

Gefitinib(吉非替尼) is a selective tyrosine kinase receptor inhibitor used in the therapy of non-small cell lung cancer.

Cabozantinib Malate(苹果酸卡博替尼) is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity.

Axitinib(阿西替尼) is an orally bioavailable tyrosine kinase inhibitor. Axitinib inhibits the VEGF and PDGF, thereby exerting an anti-angiogenic effect.

Lapatinib(拉帕替尼) is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors.

Lenalidomide(来那度胺) is a thalidomide analog with potential antineoplastic activity.

TP-0903 is a potent and selective AXL Inhibitor.

Mubritinib (莫立替尼) is a potent inhibitor of HER2/ErbB2.